Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Wiesner

Showing results (171-180 of 432) with videos related to

Pageof 44
Sort By:
Journal of Hepatology|March 9, 2000
Prevalence of diabetes mellitus in patients with end-stage liver cirrhosis due to hepatitis C, alcohol, or cholestatic diseaseN N Zein, A S Abdulkarim, R H Wiesner, et al.
Annals of Internal Medicine|November 1, 1988
Primary sclerosing cholangitis and celiac disease. A novel associationJ E Hay, R H Wiesner, R G Shorter, et al.
Alimentary Pharmacology & Therapeutics|July 12, 2012
Anti-tumour necrosis factor treatment of inflammatory bowel disease in liver transplant recipientsA B Mohabbat, W J Sandborn, E V Loftus, et al.
AJR. American Journal of Roentgenology|November 1, 1991
Primary sclerosing cholangitis: value of cholangiography in determining the prognosisD A Craig, R L MacCarty, R H Wiesner, et al.
Transplantation|August 29, 1998
Cytomegalovirus and its association with hepatic artery thrombosis after liver transplantationC Madalosso, N F de Souza, D M Ilstrup, et al.
Transplantation|February 27, 1997
Enhanced liver calpain protease activity is a risk factor for dysfunction of human liver allograftsH I Aguilar, J L Steers, R H Wiesner, et al.
Chest|May 1, 1990
Intrapulmonary vascular dilatations (IPVD) in liver transplant candidates. Screening by two-dimensional contrast-enhanced echocardiographyM J Krowka, A J Tajik, E R Dickson, et al.
Transplantation|February 2, 2013
Evolving frequency and outcomes of liver transplantation based on etiology of liver diseaseAshwani K Singal, Praveen Guturu, Bashar Hmoud, et al.
Mayo Clinic Proceedings|April 10, 2003
Effect of minimal listing criteria on waiting list registration for liver transplantation: a process-outcome analysisJayant A Talwalkar, W Ray Kim, Charles B Rosen, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 11, 2015
Impact of fibrosis progression on clinical outcome in patients treated for post-transplant hepatitis C recurrenceRenumathy Dhanasekaran, William Sanchez, Taofic Mounajjed, et al.
Pageof 44

Showing results (171-180 of 432) with videos related to

Sort By:
Pageof 44
Journal of Hepatology|March 9, 2000
Prevalence of diabetes mellitus in patients with end-stage liver cirrhosis due to hepatitis C, alcohol, or cholestatic diseaseN N Zein, A S Abdulkarim, R H Wiesner, et al.
Annals of Internal Medicine|November 1, 1988
Primary sclerosing cholangitis and celiac disease. A novel associationJ E Hay, R H Wiesner, R G Shorter, et al.
Alimentary Pharmacology & Therapeutics|July 12, 2012
Anti-tumour necrosis factor treatment of inflammatory bowel disease in liver transplant recipientsA B Mohabbat, W J Sandborn, E V Loftus, et al.
AJR. American Journal of Roentgenology|November 1, 1991
Primary sclerosing cholangitis: value of cholangiography in determining the prognosisD A Craig, R L MacCarty, R H Wiesner, et al.
Transplantation|August 29, 1998
Cytomegalovirus and its association with hepatic artery thrombosis after liver transplantationC Madalosso, N F de Souza, D M Ilstrup, et al.
Transplantation|February 27, 1997
Enhanced liver calpain protease activity is a risk factor for dysfunction of human liver allograftsH I Aguilar, J L Steers, R H Wiesner, et al.
Chest|May 1, 1990
Intrapulmonary vascular dilatations (IPVD) in liver transplant candidates. Screening by two-dimensional contrast-enhanced echocardiographyM J Krowka, A J Tajik, E R Dickson, et al.
Transplantation|February 2, 2013
Evolving frequency and outcomes of liver transplantation based on etiology of liver diseaseAshwani K Singal, Praveen Guturu, Bashar Hmoud, et al.
Mayo Clinic Proceedings|April 10, 2003
Effect of minimal listing criteria on waiting list registration for liver transplantation: a process-outcome analysisJayant A Talwalkar, W Ray Kim, Charles B Rosen, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 11, 2015
Impact of fibrosis progression on clinical outcome in patients treated for post-transplant hepatitis C recurrenceRenumathy Dhanasekaran, William Sanchez, Taofic Mounajjed, et al.
Pageof 44